Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Gliosarcoma 13Glioblastoma 12Sarcoma 3Astrocytoma 3Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Fibrosarcoma 2Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Pinealoma 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Medulloblastoma 1Kidney Neoplasms 1Hemangiopericytoma, Malignant 1Glioma, Subependymal 1Glioma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Dermatofibrosarcoma 1

Interventions

Temozolomide 4Surgical Procedures, Operative 3Magnetic Resonance Spectroscopy 3Irinotecan 2Gadolinium DTPA 2Donepezil 2Carboplatin 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2temsirolimus 1plerixafor 1omburtamab I-131 1gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1etoposide phosphate 1entinostat 1carboxyamido-triazole 1adavosertib 1Yoga 1Verteporfin 1Thiotepa 1Thalidomide 1Surveys and Questionnaires 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Radiation 1Pregabalin 1Pharmacogenomic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pinealoma × Radiotherapy, Conformal × Sarcoma × Clear all
NCT01119599 2015-09-29

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

National Cancer Institute (NCI)

Phase 1 Completed
22 enrolled
CNSSarcoma

Astrocytoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroma, Acoustic, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡